Treatment (n) | Adjusted mean (SE) | Change from baseline (95% CI) | Treatment difference (95% CI) | P value | |
Cardiac function | |||||
LVEDVI (mL/m2) | T/O (59) | 68.711 (1.136) | 2.317 (0.061 to 4.574) | –0.537 (–2.779 to 1.705) | 0.6331 |
F/S (59) | 69.249 (1.137) | 2.855 (0.597 to 5.112) | |||
RVEDVI (mL/m²) | T/O (59) | 76.237 (1.334) | 2.448 (–0.207 to 5.103) | –0.864 (–3.069 to 1.340) | 0.4356 |
F/S (59) | 77.102 (1.335) | 3.312 (0.656 to 5.968) | |||
LVESVI (mL/m2) | T/O (59) | 27.324 (0.804) | 0.647 (–0.951 to 2.245) | –0.340 (–1.841 to 1.161) | 0.6516 |
F/S (59) | 27.665 (0.804) | 0.987 (–0.612 to 2.585) | |||
RVESVI (mL/m2) | T/O (59) | 35.912 (1.074) | 0.236 (–1.894 to 2.366) | 0.257 (–2.152 to 2.666) | 0.8315 |
F/S (59) | 35.655 (1.074) | –0.021 (–2.152 to 2.110) | |||
CARDIDX (L/min/m2) | T/O (59) | 3.044 (0.075) | 0.044 (–0.104 to 0.193) | –0.036 (–0.201 to 0.130) | 0.6687 |
F/S (59) | 3.080 (0.075) | 0.080 (–0.068 to 0.228) | |||
LVSVI (mL/m2) | T/O (59) | 41.097 (0.950) | 1.523 (–0.362 to 3.409) | –0.628 (–2.676 to 1.421) | 0.5240 |
F/S (59) | 41.725 (0.951) | 2.151 (0.264 to 4.038) | |||
RVSVI (mL/m2) | T/O (59) | 39.872 (1.046) | 1.768 (–0.307 to 3.842) | –1.685 (–4.039 to 0.669) | 0.1572 |
F/S (59) | 41.557 (1.046) | 3.453 (1.377 to 5.529) | |||
LVEF (%) | T/O (59) | 60.936 (0.958) | 0.507 (–1.397 to 2.410) | 0.139 (–1.770 to 2.049) | 0.8845 |
F/S (59) | 60.797 (0.959) | 0.368 (–1.537 to 2.272) | |||
RVEF (%) | T/O (59) | 53.103 (1.124) | 0.824 (–1.404 to 3.052) | –0.833 (–3.700 to 2.035) | 0.5633 |
F/S (59) | 53.936 (1.125) | 1.657 (–0.572 to 3.886) | |||
LVMI (g/m2) | T/O (59) | 50.129 (1.000) | –0.125 (–2.112 to 1.861) | 1.021 (–0.968 to 3.010) | 0.3083 |
F/S (59) | 49.108 (1.001) | –1.146 (–3.134 to 0.841) | |||
RVMI (g/m2) | T/O (59) | 18.106 (0.605) | 0.092 (–1.107 to 1.292) | 0.754 (–0.737 to 2.244) | 0.3155 |
F/S (59) | 17.352 (0.606) | –0.661 (–1.862 to 0.539) | |||
Central systolic blood pressure (mm Hg) | T/O (58) | 115.395 (1.559) | 2.271 (–0.820 to 5.363) | 2.069 (–1.640 to 5.779) | 0.2687 |
F/S (58) | 113.325 (1.559) | 0.202 (–2.891 to 3.294) | |||
Pulse pressure (mm Hg) | T/O (58) | 45.025 (1.014) | 0.579 (–1.430 to 2.588) | 0.409 (–2.264 to 3.082) | 0.7604 |
F/S (58) | 44.616 (1.014) | 0.170 (–1.839 to 2.179) | |||
Arterial stiffness | |||||
Aortic distensibility (%/mm Hg) | T/O (57) | 0.514 (0.036) | –0.005 (–0.076 to 0.066) | 0.001 (–0.072 to 0.074) | 0.9817 |
F/S (57) | 0.513 (0.036) | –0.006 (–0.077 to 0.065) | |||
PA pulsatility (%) | T/O (57) | 30.053 (1.836) | 1.105 (–2.540 to 4.751) | 1.280 (–2.719 to 5.279) | 0.5238 |
F/S (57) | 28.773 (1.837) | –0.175 (–3.823 to 3.474) |
CARDIDX, cardiac index; F/S, fluticasone propionate/salmeterol; LVEDVI, left ventricular end-diastolic volume index; LVEF, left ventricular ejection fraction; LVESVI, left ventricular end-systolic volume index; LVMI, left ventricular mass index; LVSVI, left ventricular stroke volume index; PA, pulmonary artery; RVEDVI, right ventricular end-diastolic volume index; RVEF, right ventricular ejection fraction; RVESVI, right ventricular end-systolic volume index; RVMI, right ventricular mass index; RVSVI, right ventricular stroke volume index; T/O, tiotropium/olodaterol.